Page 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 FORM 10 - K ( Mark One ) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30 , 2021 □ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission file number : 001-37606 ANAVEX LIFE SCIENCES CORP . ( Exact name of registrant as specified in its charter ) Nevada ( State or other jurisdiction of incorporation or organization ) 630 5th Avenue , 20th Floor , New York , NY USA ( Address of principal executive offices ) to Common Stock , $ 0.001 par value Title of each class Registrant's telephone number , including area code 1-844-689-3939 Securities registered under Section 12 ( b ) of the Act : AVXL Trading Symbol 98-0608404 ( I.R.S. Employer Identification No. ) 10111 ( Zip Code ) NASDAQ Stock Market LLC Name of each exchange on which registered Securities registered pursuant to Section 12 ( g ) of the Act : None ( Title of class ) Indicate by checkmark if the registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . Indicate by checkmark if the registrant is not required to file reports pursuant to Section 13 or 15 ( d ) of the Act . Yes No Yes No Indicate by checkmark whether the registrant has ( 1 ) filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes > No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T ( §232.405 of this chapter ) during the preceding 12 months ( or for such shorter period that the registrant was required to submit and post such files ) . Yes > No